Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-04-03 to 2024-04-03
Current total value of award: $1045.35
Description: 4564157297!MIDAZOLAM HCL INJ 10S